Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03605914 · ClinicalTrials.gov registry record · Phase 4
Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03605914 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants.
The verdict
NCT03605914, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the level of pain control in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.
Interventions
- DRUG Norco
- DRUG diclofenac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-07-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03605914
The ClinicalTrials.gov registry entry for NCT03605914 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Norco is the first listed.
NCT03605914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03605914 about?
NCT03605914 is a clinical study titled "Are NSAIDs Effective Enough for Postoperative Pain Control After Functional Endoscopic Sinus Surgery and Septoplasty". The purpose of this study is to compare the level of pain control in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) to those receiving opioids in the postoperative period after endoscopic sinus surgery (ESS) and/or septoplasty.
What is the current status of trial NCT03605914?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-08-01. Estimated completion is 2020-07-05.
What interventions are being tested in trial NCT03605914?
The interventions under investigation include: Norco (DRUG), diclofenac (DRUG).
Who is sponsoring clinical trial NCT03605914?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.